Dr. Geller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8186 Lark Brown Rd
Ste 201
Elkridge, MD 21075Phone+1 410-730-3399Fax+1 410-740-4744
Education & Training
- Johns Hopkins UniversityResidency, Internal Medicine, 1985 - 1988
- Johns Hopkins University School of MedicineClass of 1985
Certifications & Licensure
- MD State Medical License 1986 - 2024
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Diabetes Recognition Program National Committee for Quality Assurance, 2010-2013
- Heart/Stroke Recognition Program National Committee for Quality Assurance, 2010-2013
Clinical Trials
- A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval Start of enrollment: 2015 Apr 01
- Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL Start of enrollment: 2017 Apr 06
- A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age Reduces the Risk of Stroke Start of enrollment: 2019 Dec 17
- Join now to see all
Publications & Presentations
PubMed
- 23 citationsRisk of post-treatment Lyme disease in patients with ideally-treated early Lyme disease: A prospective cohort study.John N Aucott, Ting Yang, Isaac Yoon, Debra Powell, Steven A Geller
International Journal of Infectious Diseases. 2022-03-01 - 4 citationsInitial Presentation and Time to Treatment in Early Lyme Disease.Alison W Rebman, Ting Yang, Isaac Yoon, Debra Powell, Steven A Geller
The American Journal of Tropical Medicine and Hygiene. 2023-04-05 - 19 citationsTreatment of fibrositis with fluoxetine hydrochloride (Prozac).Steven A. Geller
The American Journal of Medicine. 1989-11-01
Press Mentions
- COVID-19 Prevention Pill Trial in MarylandJuly 12th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: